German Federal Minister visits Vetter
Says firm makes a noteworthy contribution to pharma industry
Vetter, which employs 2,300 people across Europe and the US, is an independent international specialist in the aseptic filling of drug delivery systems for pharmaceutical and biotechnology companies.
‘Innovative, mid-sized companies like Vetter are not only an important engine of the German economy, but as successful international players, they also make a noteworthy contribution to the development of the global pharmaceutical market,’ said Niebel.
Vetter fills syringes, cartridges and vials with drugs for the treatment of cancer, multiple sclerosis and rheumatoid arthritis.
‘We are pleased to receive a high-level visit from Germany’s capital,’ said Udo Vetter, partner and chairman of the company’s advisory board. ‘We have grown steadily since our founding and are among the leading providers in our segment. A visit by Federal Minister Niebel underscores that a family run mid-sized company can be a successful global player.’
